<DOC>
	<DOCNO>NCT01507155</DOCNO>
	<brief_summary>Genomind develop introduce battery genetic test , Genecept Assay , clinician administer patient use simple saliva sample technique . The present study propose enroll 1 . Subjects ( patient consent use Genecept Assay ) 2 . Clinician study participant ( clinician order Assay behalf patient ) . This study involve collection response Subjects clinician study participant intention correlate information Subject genetic data .</brief_summary>
	<brief_title>An Open Label Study Clinical Utility Patient Outcomes Genecept Assay</brief_title>
	<detailed_description>This 3-month prospective study clinician order Genecept assay psychiatric patient test order . Clinicians order Assay patient indicate diagnosis depression receive invitation participate study well informational patient study brochure test kit . The patient 's treat clinician prompt discus study patient . Clinicians patient view website contain additional information study well inform consent document . Potential subject clinician study participant consent online use secure electronic method . Study staff available phone email answer question relate study inform consent document process . Clinicians patient choose participate independently one party decline enroll , may still participate . Whether choose participate , patient must consent allow clinician provide response treatment . All subject participant receive username password access secure study portal completion study survey . Subjects participant receive sm email reminder survey due . At baseline , clinician study participant supervise DNA sample collection prompt complete brief survey contain question patient 's psychiatric history severity illness , current treatment regimen treatment intention clinician prior receive genetic result . After receive result Assay , clinician study participant prompt complete online study survey contain question related impact Genecept Assay treatment diagnosis decision . The subject continue treatment determine clinician study participant . At 3 month baseline , clinician study participant ask complete online survey additional question relate subsequent change patient 's treatment regimen illness severity since receiving/implementing result Assay . The subject also prompt complete survey baseline , 1 month receipt genetic result 3 month receipt genetic result . These survey include question patient 's psychiatric symptom , quality life medication side effect . The 3 month patient assessment also include satisfaction questionnaire .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Depressive Disorder , Treatment-Resistant</mesh_term>
	<criteria>Clinician Study Participants : Valid National Provider Identifier ( NPI ) number prescribe privilege Signed electronic informed consent Signed requisition form order Genecept Assay Requisition form include indication diagnosis depression anxiety patient Subject Study Participants : Ability complete electronic informed consent ; include : access appropriate technology ( i.e . internetconnected device , internet connection ) , cognitively competent &gt; = 18 year old time DNA sample collection Indication diagnosis depression anxiety requisition form Clinician Study Participants : Inability complete online questionnaire Subject Study Participants : Inability complete online questionnaire ; include : lack access appropriate technology ( i.e . internetconnected device , internet connection ) , cognitive impairment &lt; 18 year old time DNA sample collection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Major</keyword>
	<keyword>Depressive</keyword>
	<keyword>Disorder</keyword>
	<keyword>Depression</keyword>
	<keyword>MDD</keyword>
	<keyword>Treatment Resistant</keyword>
	<keyword>Anxiety</keyword>
	<keyword>GAD</keyword>
</DOC>